Navigation Links
A cost-effective way toward personalized cancer drugs
Date:10/25/2013

inescent dye, allowing them to use the assay to determine how much ATP is present. The lower the concentration of ATP a sample shows, the more effective the drug.

The process is entirely automated and is carried out under sterile conditions. This increases both the quality and the stability of the assay compared to tests conducted manually. Christian Reis, head of the bioprocess engineering group at Fraunhofer PAMB, outlines the advantages of the process: "In addition to optimizing and standardizing tumor analysis, automation mainly serves to make it cost effective. It will now be possible to deliver the most effective drugs possible, tailored to each individual cancer patient." And by helping to eliminate ineffectual courses of chemotherapy, the new method can even help drive down healthcare costs.

The system's modular structure, meaning it can be easily adapted to fit changing require-ments, is yet another advantage. Visit the joint Fraunhofer booth (E09) in Hall 9 at BIOTECHNICA 2013 to discover just how DiagnoSYS works.


'/>"/>

Contact: Axel Storz
axel.storz@ipa.fraunhofer.de
49-711-970-3660
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Researchers develop rapid, cost-effective early detection method for organ transplant injury
2. Cost-effective: Universal HIV testing in India
3. A new cost-effective genome assembly process
4. Cost-effective production of infrared lenses
5. Towards a real understanding of depression
6. Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find
7. Toward understanding the dangers of the fake marijuana called Spice or K2
8. Insect-inspired super rubber moves toward practical uses in medicine
9. Toward a safer form of acetaminophen
10. New materials, progress toward an HIV vaccine, and more at meeting of crystallographers
11. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A cost-effective way toward personalized cancer drugs
(Date:9/30/2014)... New England Journal of Medicine reports positive ... drug crizotinib against the subset of lung cancer marked ... study of 50 patients with advanced non-small cell lung ... rate was 72 percent, with 3 complete responses and ... it takes for the disease to resume its growth ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... perilous threats in today,s ocean. From overfishing and ... coral ecosystems are disappearing at unprecedented rates around ... corals surrounding the island of Moorea in French ... environment: coral guard-crabs. New research from the National ... Seabird McKeon and the museum,s predoctoral fellow Jenna ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
... Genetic factors explain some of the variation in a ... such as preferences toward environmental policy and financial ... variants are likely to be very small, according to ... Daniel Benjamin. The research team arrived at the ...
... by the European Commission,s in-house science service, the Joint Research ... managers on how to assess the environmental impacts of products ... resource-efficient Europe and aims to help design more sustainable products, ... and limited resources. , The increasing world population and ...
... created an ultrasensitive biosensor that could open up ... "personalized medicine" tailored to the specific biochemistry of ... several hundred times more sensitive than other biosensors, ... of sensors, said Muhammad A. Alam, a Purdue ...
Cached Biology News:New evidence that many genes of small effect influence economic decisions and political attitudes 2A practical guide to green products and services 2Ultrasensitive biosensor promising for medical diagnostics 2
(Date:9/30/2014)... Los Angeles, CA (PRWEB) September 30, 2014 ... Separation (EWS), the high-speed, chemical-free process to clean up ... letter to shareholders, CEO Riggs Eckelberry reported on the ... West Texas, at a site provided by partner ... ramped up to 1000 barrels per day (bpd) and ...
(Date:9/30/2014)... 30, 2014 iLab Solutions announced the ... study which focuses on core facility operations, growth ... managers face today. , In its 4th year running, ... note is the year-over-year decrease in the percentage of ... to be feeling the constraints of this trend. When ...
(Date:9/30/2014)... MA (PRWEB) September 30, 2014 ... (UC) and collaboration company is dedicated to supporting ... connectivity needs. Julie Power, a carrier ... to ensure collaboration solutions stays connected and productive ... to the increased movement of businesses to cloud ...
(Date:9/30/2014)... Jersey (PRWEB) September 30, 2014 ... has been chosen by the Parenteral Drug Association ... 18 and 19, 2014) on container closure integrity testing. ... closure integrity test methods and philosophies detailed in the ... Integrity Evaluation. The course will span container ...
Breaking Biology Technology:OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3SoundConnect Expands Carrier Services Division 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4
... Oct. 26, 2011 The following is a letter ... Ltd. (OTCBB: HADSY), a publicly traded portfolio of biotech ... Hadassah University Hospital. Dear Fellow Investors, ... establishment by the Hadassah University Hospital and its IPO ...
... this smorgasbord of recent salmonella outbreaks in the United ... 2011 alone, and the list goes on, according to ... perhaps not for long, thanks to a promising new ... bacteria before contaminated food or animals reach the marketplace. ...
... and IPSWICH, Mass., Oct. 25, 2011 SwitchGear ... services for studying regulatory elements in the human genome, ... Inc. (NEB) to create a new dual reporter assay ... Luciferase Assay System and NEB,s BioLux® Cypridina ...
Cached Biology Technology:Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 3Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 4Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 5Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 6SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System 2
... Mouse polyclonal antibody raised against ... Immunogen: PPP4C ... a.a) partial recombinant protein with ... Accession Number: NM_002720 ...
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
... II can be used to test the ... and sera that are commonly used as ... contains spots for 19 different protein preparations ... antibody crossreactivity and species specificity, QC of ...
Biology Products: